Have a personal or library account? Click to login
Evaluation of the prevalence and laboratory test results of overt thyrotoxicosis cases Cover

Evaluation of the prevalence and laboratory test results of overt thyrotoxicosis cases

Open Access
|Mar 2024

References

  1. TÜRKIYE ENDOKRINOLOJI VE METABOLIZMA DERNEĞI. Hipertiroidi ve Tirotoksikoz. Tiroid Hastalıkları Tanı ve Tedavi Klavuzu. 2023: 95-109.
  2. SHARMA A, STAN MN. Thyrotoxicosis: Diagnosis and Management. Mayo Clin Proc. 2019; 94(6): 1048-1064.
  3. VAN SOESTBERGEN M, VAN DER VIJVER J, GRAAFLAND A. Recurrence of hyperthyroidism in multinodular goiter after long-term drug therapy: a comparison with Graves’ disease. Journal of endocrinological investigation. 2012; 15(11): 797-800.
  4. DE LEO S, LEE SY, BRAVERMAN LE. Hyperthyroidism. Lancet (London, England). 2016; 388(10047): 906-18.
  5. ALFADDA AA, SALLAM RM, ELAWAD GE, ALDHUKAIR H, ALYAHYA MM. Subacute thyroiditis: clinical presentation and long term outcome. Int J Endocrinol. 2014;2014:794943.
  6. ROSS DS, BURCH HB, COOPER DS, GREENLEE MC, LAURBERG P, MAIA AL, et al. American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 2016; 26(10):1343-1421
  7. AZEEZ TA, LAMIDI AO, OSIN IO. A systematic review and meta-analysis of the etiology and treatment patterns of thyrotoxicosis in Africa. Expert Rev Endocrinol Metab. 2022; 17(6):563-572
  8. DAĞLI Ş. AİBÜ. İzzet Baysal Tıp Fakültesi Hastanesi, İç Hastalıkları polikliniğine 2007 yılında başvuran hastalardaki tiroid patolojilerinin dağılımı.
  9. KINOSHITA S, HAYASHI T, WADA K, YAMATO M, KUWAHARA T, ANZAI T, et al. Risk factors for amiodarone-induced thyroid dysfunction in Japan. J Arrhythm. 2016; 32: 474-480.
  10. BEDNARCZUK T, BRIX TH, SCHIMA W, ZETTINIG G, KAHALY GJ. European Thyroid Association Guidelines for the Management of Iodine-Based Contrast Media-Induced Thyroid Dysfunction. Eur Thyroid J. 2021;10(4):269-284.
  11. MAMMEN JS, MCGREADY J, OXMAN R, CHİA CW, LADENSON PW, SİMONSİCK EM. Thyroid Hormone Therapy and Risk of Thyrotoxicosis in Community-Resident Older Adults: Findings from the Baltimore Longitudinal Study of Aging. Thyroid : Official Journal of the American Thyroid Association. 2015; 25(9):979-986.
  12. DE BENOIST B, ANDERSSON M, TAKKOUCHE B, EGLI I. Prevalence of iodine deficiency worldwide. Lancet (London, England). 2003; 362(9398): 1859-60.
  13. ROSS DS. Treatment of toxic adenoma and toxic multinodular goiter. UpToDate 12th ed. Waltham, MA: Wolters Kluwer. 2019.
  14. NOVODVORSKY P, ALLAHABADIA A. Thyrotoxicosis. Medicine. 2017; 45(8): 510-516.
  15. AKBAR DH, MUSHTAQ MM, AL-SHEIK AA. Etiology and outcome of thyrotoxicosis at a university hospital. Saudi medical journal. 2000; 21(4): 352-4.
  16. BLICK C, NGUYEN M, JIALAL I. Thyrotoxicosis In: StatPearls [Internet]. Treasure Island (FL) StatPearls Publishing. 2022.
  17. ERGÜN Y, TUZCU AK. Subakut tiroidit tanılı hastaların demografik özellikleri ve laboratuvar verilerinin analizi: tek merkez deneyimi. Ege Tıp Dergisi. 2019; 58(3): 282-288.
  18. TURA BAHADIR Ç, YILMAZ M, KILIÇKAN E. Free triiodothyronine to free thyroxine ratio in the differential diagnosis of thyrotoxicosis and hyperthyroidism: A retrospective study. Int J Clin Pract. 2021; 75:e14003
DOI: https://doi.org/10.2478/rjim-2024-0007 | Journal eISSN: 2501-062X | Journal ISSN: 1220-4749
Language: English
Page range: 272 - 278
Submitted on: Oct 7, 2023
Published on: Mar 12, 2024
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2024 Rabia Ezber, Ebru Demir Ülgen, İhsan Ateş, Nisbet Yilmaz, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.